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AKT/GSK-3β signalingMutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene have been identiﬁed in a
neurodevelopmental disorder characterized by early-onset intractable seizures, severe developmental delay, in-
tellectual disability, and Rett's syndrome-like features. Since the physiological functions of CDKL5 still need to be
elucidated, in the current studywe took advantage of a new Cdkl5 knockout (KO)mouse model in order to shed
light on the role of this gene in brain development. We mainly focused on the hippocampal dentate gyrus, a re-
gion that largely develops postnatally and plays a key role in learning and memory. Looking at the process of
neurogenesis, we found a higher proliferation rate of neural precursors in Cdkl5 KO mice in comparison with
wild typemice. However, there was an increase in apoptotic cell death of postmitotic granule neuron precursors,
with a reduction in total number of granule cells. Looking at dendritic development, we found that in Cdkl5 KO
mice the newly-generated granule cells exhibited a severe dendritic hypotrophy. In parallel, these
neurodevelopmental defects were associated with impairment of hippocampus-dependent memory. Looking
at themechanisms whereby CDKL5 exerts its functions, we identiﬁed a central role of the AKT/GSK-3β signaling
pathway. Overall our ﬁndings highlight a critical role of CDKL5 in the fundamental processes of brain develop-
ment, namely neuronal precursor proliferation, survival andmaturation. This evidence lays the basis for a better
understanding of the neurological phenotype in patients carrying mutations in the CDKL5 gene.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Mutations in the CDKL5 (cyclin-dependent kinase-like 5) gene are
associatedwith a severe X-linked neurodevelopmental disorder charac-
terized by severe intellectual disability, generalized developmental
delay, early-onset intractable seizures, infantile spasms, and Rett's syn-
drome (RTT)-like features. This condition affectsmostly girls and, due to
the numerous features that overlap with RTT, it has initially been
termed a variant of RTT (Evans et al., 2005; Scala et al., 2005; Tao
et al., 2004;Weaving et al., 2004). RTT is a neurodevelopmental disorder
that affects young females and shares mental retardation, hyperventila-
tion, hand stereotypies and hypotoniawith CDKL5-related disorder. The
majority of RTT cases are heterozygous for missense or nonsense muta-
tions in the gene encoding for methyl-CpG-binding protein 2 (MeCP2)
(Cheadle et al., 2000). Several CDKL5 gene mutations, resulting innd Neuromotor Sciences, Piazza
2091737.
ect.com).
. This is an open access article undermissense, nonsense, splice, and frameshift mutations or genomic dele-
tions have been described in girls (heterozygous mutations) and a few
boys, with all subjects presenting early onset intractable seizures
(Bahi-Buisson et al., 2008a, 2008b). Due to the different CDKL5muta-
tions and the variable X inactivation in females, the phenotypic spectrum
of the disease spans from milder forms—which include the possibility
of autonomous walking and less severe epilepsy that is amenable to
control—to severe forms featuring intractable seizures, more severe
microcephaly and the absence ofmotormilestones. Themale phenotype
always falls in the severe spectrum form (Guerrini and Parrini, 2012).
CDKL5, also known as STK9, is a serine/threonine protein kinase that
maps to chromosome region Xp22 region. The CDKL5 gene is composed
of 20 coding exons and codes for a protein of 1030 amino acids (Mari
et al., 2005). Mutations in the CDKL5 gene are mainly located within
the catalytic domain, strongly suggesting that impaired CDKL5 catalytic
activity may play an important role in the pathogenesis of this enceph-
alopathy (Bahi-Buisson et al., 2012; Tao et al., 2004). Thus, knowledge of
themolecular targets of CDKL5may help shed light on the role of CDKL5
in neurodevelopment. The CDKL5 substrates identiﬁed so far are DNA
methyltransferase 1 (DNMT1) (Kameshita et al., 2008), MeCP2the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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et al., 2013), indicating that CDKL5 may regulate targets both at the nu-
clear (DNMT1 and MeCP2) and cytoplasmatic level. Moreover, CDKL5
has been shown to bind to the scaffolding protein postsynaptic density
(PSD)-95 and to the synaptic cell adhesion molecule NGL-1, thereby
inﬂuencing dendritic spine formation and growth (Ricciardi et al.,
2012; Zhu et al., 2013). This is in agreement with a recent loss-of-
function study using RNA interference (RNAi) showing that CDKL5 is
required for neurite growth (Chen et al., 2010).
CDKL5 is highly expressed in the brain, mainly in neurons with both
a nuclear and dendrite localization (Chen et al., 2010; Ricciardi et al.,
2012; Rusconi et al., 2008; Zhu et al., 2013). In the early postnatal peri-
od, CDKL5 brain expression exhibits a peak (Ricciardi et al., 2012; Zhu
et al., 2013), suggesting its potential importance in brain maturation
and function. However, the role/s of CDKL5 in brain development and
the molecular mechanisms whereby CDKL5 exerts its effects are still
largely unknown. Recently, Cdkl5 knockout (KO) mouse models have
been created (Amendola et al., 2014;Wang et al., 2012), in order to un-
derstand the etiology of the CDKL5 disorder phenotype. A ﬁrst charac-
terization of these mice showed that loss of CDKL5 results in autistic-
like behavioral abnormalities, decreased dendritic branching of cortical
neurons, impairment of neural circuit communication, and alterations
in AKT-mTor-S6 pathway (Amendola et al., 2014; Wang et al., 2012).
Using neuroblastoma cell lines as a neuronal model, we recently
found that CDKL5 affects both neurite growth and cell proliferation
(Valli et al., 2012), suggesting that CDKL5 may modulate not only den-
dritic maturation, as shown by Chen et al. (2010) but also cell prolifera-
tion in the developing brain. In rodents, the hippocampal dentate gyrus
produces its neurons mainly postnatally (Aimone et al., 2010; O'Kusky
et al., 2000). This makes the hippocampus an ideal structure for the ex-
amination of the role of CDKL5 on fundamental neurodevelopmental
processes such as neurogenesis and dendritic development. In the cur-
rent study we used a Cdkl5 KO mouse model in order to dissect the
role of CDKL5 in hippocampal development and to establish the mech-
anism/s underlying its actions. Because of the novelty of this model we
have included in our study homozygous and heterozygous females and
hemizygous males, in order to clarify the genotype-related severity of
the phenotype.
Materials and methods
Colony
Mice for testing were produced by crossing Cdkl5 KO +/− females
with Cdkl5 KO Y/−males and Cdkl5 KO +/− females with Y/+ males
(Amendola et al., 2014). Littermate controls were used for all experi-
ments. Animals were karyotyped by PCR on genomic DNA using the fol-
lowing primers: 108 F: 5′-ACGATAGAAATAGAGGATCAACCC-3′, 109R:
5′ CCCAAGTATACCCCTT TCCA-3′; 125R: 5′-CTGTGACTAGGGGCTAGA
GA-3′. The day of birth was designed as postnatal day (P) zero and ani-
mals with 24 h of age were considered as 1-day-old animals (P1). After
weaning, mice were housed three to ﬁve per cage on a 12-h light/dark
cycle in a temperature-controlled environment with food and water
provided ad libitum. Experiments were performed in accordance with
the Italian and European Community law for the use of experimental
animals andwere approved byBolognaUniversity Bioethical Committee.
In this study all efforts were made to minimize animal suffering and to
keep the number of animals used to a minimum. A total of 128 animals
were used. Supplementary Table 1 summarizes the different experimen-
tal groups, their genotype, sex and the experimental procedures used.
BrdU injection
On P40, some animals received one daily intraperitoneal injection
(150 μg/g body weight) of BrdU (5-bromo-2-deoxyuridine; Sigma) in
0.9% NaCl solution for ﬁve consecutive days. Animals were sacriﬁcedeither 24 h after the last BrdU injection (on P45) or after 1 month
(on P75) (Supplementary Table 1).
Histological procedures
Some animals (Supplementary Table 1) were deeply anesthetized
with ether and transcardially perfused with ice cold phosphate-
buffered saline (PBS), followed by a 4% solution of paraformaldehyde
in 100 mM PBS, pH 7.4. Brains were stored in the ﬁxative for 24 h, cut
along themidline and kept in 20% sucrose in phosphate buffer for an ad-
ditional 24 h. Hemispheres were frozen and stored at−80 °C. The right
hemisphere was cut with a freezing microtome into 30-μm-thick coro-
nal sections thatwere serially collected in antifreeze solution containing
sodium azide. Some animals (Supplementary Table 1)were decapitated
and the brain was removed, cut along the midline and ﬁxed by immer-
sion in Glyo-Fixx (Thermo Electron Corp., Waltham, MA, USA) for 48 h.
Samples were dehydrated through a series of ascending ethanol
concentrations, embedded in parafﬁn, and cut with a microtome into
ultra-thin sections (4 μm) and mounted on poly-lysine slides.
Sections from the dentate gyrus (DG) and subventricular zone (SVZ)
were used for immunohistochemistry andNissl staining. The SVZ of this
study corresponds to the rostral horn of the lateral ventricle and starts at
the rostral pole of the lateral ventricle, stretching for 900–1200 μm
in the caudal direction. Its rostral and caudal borders correspond
approximately to +1.18 mm and +0.02 mm planes, respectively, of
the Franklin and Paxinos atlas of the mouse brain.
Immunohistochemistry and double-ﬂuorescence immunohistochemistry
One out of six 30-μm-thick coronal sections from the DG and the
SVZ of animalswere processed for immunohistochemistry as previously
described (Bianchi et al., 2010; Contestabile et al., 2007). Immunohisto-
chemistry was carried out on free-ﬂoating sections of the frozen brains.
For BrdU immunohistochemistry, sections were denatured in 2 N
HCl for 30 min at 37 °C and incubated overnight at 4 °C with a primary
antibody anti-BrdU (mouse monoclonal 1:100, Roche Applied
Science, Mannheim, Germany). Detection was performed with a Cy3-
conjugated anti-mouse secondary antibody (dilution 1:200; Jackson
Immunoresearch,WestGrove, PE, USA). For Ki-67 immunohistochemis-
try, sections were incubated overnight at 4 °C with rabbit monoclonal
anti-Ki67 antibody (1:200; Thermo Scientiﬁc Neumarkers, Fremont,
CA. USA) and for 2 h with a Cy3 conjugated anti-rabbit IgG (1:200;
Jackson Immunoresearch). For cleaved caspase-3 immunohistochemis-
try, sections were incubated overnight at 4 °C with a rabbit cleaved
caspase-3 antibody (1:200; Cell Signaling Technology) and for 2 h
with an HRP-conjugated anti-rabbit secondary antibody (dilution
1:200; Jackson Immunoresearch). Detection was performed using the
TSA Cyanine 3 Plus Evaluation Kit (Perkin Elmer). For synaptophysin
immunohistochemistry, sections from the DG were incubated for 48 h
at 4 °C with mouse monoclonal anti-SYN (SY38) antibody (1:1000,
MAB 5258, Millipore Bioscience Research Reagents) and for 2 h with a
Cy3 conjugated anti-mouse IgG secondary antibody (1:200; Jackson
Immunoresearch). For doublecortin (DCX) immunohistochemistry, sec-
tions from the DG were incubated overnight at 4 °C with a goat poly-
clonal anti-DCX antibody (1:100; Santa Cruz Biotechnology). Sections
were then incubated for 2 h at room temperature with a biotinylated
anti-goat IgG secondary antibody (1:200; Vector Laboratories) and
thereafter incubated for 1 hwith VECTASTAIN®ABC kit (Vector Labora-
tories). Detection was performed using DAB kit (Vector Laboratories).
For double-ﬂuorescence immunostaining, sections were incubated
overnight at 4 °C with a primary antibody rat monoclonal anti-BrdU
antibody (1:100; AbD Serotec, Kidlington, Oxford, UK) and one of
the following primary antibodies: i) mouse monoclonal anti NeuN
(1: 250; Chemicon, Billerica, MA, USA) and ii) mouse monoclonal anti-
glial ﬁbrillary acidic protein (GFAP) (1:400; Sigma) or with a monoclo-
nal anti-Nestin antibody (1:200; Chemicon, Billerica, MA, USA) and
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were then incubated with a Cy3 conjugated anti-rat or anti-mouse IgG
(1:100; Jackson Immunoresearch) secondary ﬂuorescent antibody, for
BrdU or Nestin immunohistochemistry, respectively, a FITC conjugated
anti-mouse IgG antibody (1:100; Sigma-Aldrich) for NeuN and
GFAP, and a FITC conjugated anti-rabbit IgG antibody (1:100; Jackson
Immunoresearch) for cleaved caspase-3 immunohistochemistry.
Fluorescent images were taken with an Eclipse TE 2000-S microscope
(Nikon, Tokyo, Japan) equipped with an AxioCam MRm (Zeiss,
Oberkochen, Germany) digital camera or with a Leica TCS confocal mi-
croscope (Leica Microsystems, Wetzlar, Germany).
Ultra-thin consecutive sections were deparafﬁnized, incubated with
a goat anti-DCX antibody (1:100; Santa Cruz Biotechnology) or with a
rabbit cleaved caspase-3 antibody (1:200; Cell Signaling Technology).
Sections were then incubated for 2 h at room temperature with a bio-
tinylated anti-goat IgG secondary antibody (1:200; Vector Laboratories)
or a biotinylated anti-rabbit IgG secondary antibody (1:200; Vector
Laboratories) and thereafter incubated for 1 h with VECTASTAIN® ABC
kit (Vector Laboratories). Detection was performed using DAB kit (Vec-
tor Laboratories).
Measurements
Cell counting
The total number of positive cells (BrdU, Ki-67, NeuN/BrdU, GFAP/
BrdU, cleaved caspase-3, Nestin/cleaved caspase-3, DCX)was estimated
by multiplying the number counted in the series of sampled sections
by the inverse of the section sampling fraction (section sampling
fraction = 1/6).
Stereology of the DG
In the series of Nissl-stained sections, the volume of the granule cell
layer was estimated as previously described (Bianchi et al., 2010;
Contestabile et al., 2007) by multiplying the sum of the cross-sectional
areas by the spacing between sampled sections. Granule cell numerical
density was determined using the optical fractionators (Bianchi et al.,
2010). Counting frames with a side length of 30 μm and a height of
8 μm spaced in a 150 μm square grid (fractionator) were systematically
used. The total number of granule cells was estimated as the product of
the volume of the granule cell layer and the numerical density.
Measurement of the dendritic tree
Dendritic trees of DCX positive granule cells of the DG were traced
with a dedicated software, custom-designed for dendritic reconstruc-
tion (Immagini Computer, Milan, Italy), interfaced with Image Pro Plus
(Media Cybernetics, Silver Spring, MD, USA). The dendritic tree was
traced live, at a ﬁnal magniﬁcation of 500×, by focusing into the depth
of the section. The operator starts with branches emerging from the
cell soma and after having drawn the ﬁrst parent branch goes on with
all daughter branches of the next order in a centrifugal direction. At
the end of tracing the program reconstructs the number and length of
individual branches, the mean length of branches of each order and
total dendritic length.
Connectivity in the molecular layer of the DG
To evaluate the connectivity in themolecular layer of the DG, inten-
sity of SYN immunoreactivity (IR) was determined by optical densitom-
etry of immunohistochemically-stained sections. Fluorescence images
were captured using a Nikon Eclipse E600 microscope equipped with
a Nikon Digital Camera DXM1200 (ATI system). Densitometric analysis
of SYN in the inner (I), middle (M) and outer (O) third of themolecular
layer was carried out using Nis-Elements Software 3.21.03 (Nikon). For
each image, the intensity threshold was estimated by analyzing the
distribution of pixel intensities in the image areas that did not contain
IR. This value was then subtracted to calculate the IR of each sampled
area.Western blotting
The following antibodies were used: anti-GAPDH (1:5000) and
anti-CDKL5 (1:500) (Sigma); anti-phosphorylated Erk1/2 (1:1000), anti
Erk1/2 (1:1000), anti-phospho-AKT-Ser473 (1:1000), anti-phospho-
AKT-Thr308 (1:1000), anti-AKT (1:1000), anti-phospho-GSK-3β-Ser9
(1:1000), anti-GSK-3β (1:1000), anti-phospho-CRMP2-Thr514 (1:1000)
and anti-CRMP2 (1:1000) (Cell Signaling Technology); anti β-catenin
(1:1000; BD Transduction Laboratories); anti-phospho-CREB-Ser133
(1:1000) and anti-CREB (1:1000) (Upstate Biotechnology). For the prep-
aration of total cell extracts, cells were lysed in RIPA buffer (Tris–HCl 50
mM, NaCl 150 mM, Triton X-100 1%, sodium deoxycholate 0.5%, SDS
0.1%, protease and phosphatase inhibitors cocktails 1%; Sigma). For the
preparation of tissue extracts, the hippocampi from P19 mice were
homogenized in RIPA buffer. Extracts were immediately processed by
Western blot or kept frozen (−80 °C) until assayed. Sample protein con-
centration was estimated using the Lowry method (Lowry et al., 1951).
Equivalent amounts (50 μg) of protein were subjected to electrophoresis
on a 10% SDS-polyacrylamide gel. Densitometric analysis of digitized im-
ages was performed using Scion Image software (Scion Corporation,
Frederick, MD, USA) and intensity for each band was normalized to the
intensity of the respective total protein levels or GAPDH band.
Y-maze test
Y-Maze Spontaneous Alternation was used to measure the willing-
ness of mice to explore new environments and hippocampus-
dependent spatial reference memory. This test was administered at
2 months of age. Each mouse was placed at the distal part of one arm
facing the center of the maze. Each of the three arms was 34 cm ×
5 cm × 10 cm height, angled 120° from the others and made of gray
opaque plastic. After introduction into the maze, the animal is allowed
to freely explore the three arms for 8 min. Over the course of multiple
entries into the arm, the subject should show a tendency to enter a
less recently-visited arm. Arm entries were deﬁned by the presence of
all four paws in an arm. The 8-min trial was recorded and scored via
the ANY-maze videotracking software (Stoelting). The maze was
cleaned with 50% ethanol after each trial. The percentage of spontane-
ous alternations is deﬁned as: (total alternations/total arm entries−
2)× 100. One alternation is deﬁned as consecutive entries into three dif-
ferent arms. Because of the novelty of the animal model, and in order to
avoid biases related to the procedure of animal selection, we decided
that all the animals generated in the lab in one breeding session
would be included for behavioral testing. This explains the unequal
group number composition. Bartlett's test for equal variances gave neg-
ative results, thus indicating that the unequal group composition did
not affect the ANOVA analysis of Y-maze data. Finally, animals that
had not completed at least 10 entries were excluded from analysis.
This led to the exclusion of six animals, equally distributed among the
different genotypes.
NPC cultures and treatments
Cells were isolated from the subventricular zone (SVZ) of newborn
(P1–P2) Cdkl5 KO +/+, Cdkl5 KO −/− and Cdkl5 KO +/− female
mice. To obtain neurospheres, cells were cultured in suspension in
DMEM/F12 (1:1) containing B27 supplements (2%), FGF-2 (20 ng/ml),
EGF (20 ng/ml), heparin (5 μg/ml), penicillin (100 units/ml), and
antibiotics, as previously reported (Trazzi et al., 2011). Primary
neurospheres were dissociated at days 7–8 using Accutase (PAA,
Pasching, Austria) to derive secondary neurospheres. The sub-
culturing protocol consisted of neurosphere passaging every 7 days
with whole culture media change (with freshly added FGF-2 and
EGF). All experiments were done using neurospheres obtained after
one to three passages from the initially prepared cultures. Cell cultures
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(2 mM; Sigma) was administrated on alternate days.
Viral particles transduction
NPCs were infected, at day 1 post-plating, with CDKL5 adenovirus
particles (Vector BioLabs) or GFP adenovirus particles (Vector BioLabs)
at 100 multiplicities of infection (MOI).
BrdU immunocytochemistry
For proliferation analysis dissociated neurospheres were cultured
for 3 days, treatedwith 10 μMBrdU for an additional 16 h andharvested
onto microscope slides by cytospin centrifugation (215 × g, 5 min,
Shandon, Thermo, Dreieich, Germany). Specimens, processed as previ-
ously described (Contestabile et al., 2009), were incubated with a
mouse anti-5-bromo-2-deoxyuridine (BrdU) monoclonal antibody
(1:100; Roche Applied Science) and a Cy3-conjugated anti-mouse
secondary antibody (1:200; Sigma). Samples were counterstained
with Hoechst-33258.
In vitro differentiation, immunocytochemistry and analysis of neurite
length
Neurospheres were dissociated into a single cell suspension and
plated onto poly-L-ornithyine-coated 24-well chamber slides at a densi-
ty of 3 × 104 cells perwell. Cells were cultured for 2 days in a DMEM/F12
medium containing EGF (20 ng/ml), FGF (20 ng/ml) and 2% fetal bovine
serum (FBS), and then transferred to a differentiationmedium (EGF and
FGF free plus 1% FBS) for 6 or 12 days. Every 2 days, half of themedium
was replaced with fresh differentiation medium. For immunoﬂuores-
cent staining, differentiated NPC cultures were paraformaldehyde-
ﬁxed and stained with antibodies against: GFAP (1:400; Sigma) and
β-tubulin III (1:100; Sigma) as primary antibodies, and with mouse
FITC-conjugated (1:200; Sigma) and rabbit Cy3-conjugated (1:200;
Jackson Laboratories), as secondary antibodies. Samples were counter-
stained with Hoechst-33258. Ten random ﬁelds from each coverslip
were photographed and counted. The number of positive cells for each
marker referred to the total number of Hoechst-stained nuclei. Evalua-
tion of neurite length was performed by using the image analysis
system Image Pro Plus (Media Cybernetics, Silver Spring, MD, USA).
The average neurite length per cell was calculated by dividing the
total neurite length by the number of cells counted in the areas.
Statistical analysis
Data are expressed as mean ± SE, and statistical signiﬁcance was
assessed by a two-way analysis of variance (ANOVA), followed by
Bonferroni's post hoc test, Dunnet's test or by the two-tailed t-test.
Signiﬁcance was set to p ≤ 0.05. Statistical analysis was performed
using GraphPad Prism 4.0.
Results
Loss of Cdkl5 increases proliferation rate in the dentate gyrus
In order to establish whether lack of Cdkl5 affects progenitor cell
proliferation in the hippocampal dentate gyrus (DG), wild type and
Cdkl5 KO mice aged 40 days (P40) were injected for ﬁve consecutive
days with BrdU and sacriﬁced 24 h after the last BrdU injection. Since
Cdkl5 is localized on the X chromosome, the genotypes deriving from
inactivation of the Cdkl5 gene are: homozygous females (Cdkl5−/−),
heterozygous females (Cdkl5+/−) and hemizygous males (Cdkl5−/
Y). Observation of images from wild type (Cdkl5+/+) and Cdkl5−/−
females showed that KO females had more BrdU positive cells than
their wild type littermates (Fig. 1A). A quantitative analysis revealed
that the number of BrdU positive cells was higher in both Cdkl5−/−
and Cdkl5−/Y (+20 ± 1.7% and +23 ± 2.1%, respectively; p b 0.01
Bonferroni's test after ANOVA) compared to wild type mice (Fig. 1B).The number of BrdU positive cells in Cdkl5+/−mice showed a slight
but not signiﬁcant increase in comparison with wild type females
(Fig. 1B), which may be consistent with a mosaic of knockout and
wild type cells as a result of X-inactivation (Goto and Monk, 1998).
Similar results were obtained with immunohistochemistry for Ki-67,
an endogenous marker of actively proliferating cells (Fig. 1C, D). The in-
creased proliferative ability of neuronal precursor cells due to the lack of
Cdkl5 expression suggests that this gene exerts a negative role on cell
proliferation.
Loss of Cdkl5 reduces the survival rate of newborn cells in the dentate gyrus
In order to evaluate the survival rate of the newborn cells, we count-
ed the number of BrdU positive cells present in the DG 30 days after
BrdU administration, in mice aged 75 days (P75). Most of the surviving
cells were located in the granule cell layer, the ﬁnal destination of new
granule neurons. We found that both Cdkl5−/− and Cdkl5−/Y mice
had the same number of BrdU labeled cells as wild type mice
(Fig. 2A). This suggests that the surplus of cells born at P45 in
Cdkl5−/− and Cdkl5−/Ymicewas offset by a reduction in the survival
rate. The ratio between the number of BrdU positive cells present in the
DG at 1 month (Fig. 2A) and 2 h (Fig. 1B) after the last BrdU injection
provides an estimate of the net survival rate. We found that in wild
type mice 50% of the cells born at P45 survived, whereas in Cdkl5−/−
mice 39 ± 1.2% of the original cells survived (p b 0.01 Bonferroni's
test after ANOVA) and in Cdkl5−/Y mice 43 ± 1.9% survived (p b 0.01
Bonferroni's test after ANOVA). A signiﬁcant difference in cell survival
rate was also found in Cdkl5+/− compared to wild type mice (45 ±
1.7 %; p b 0.01 Bonferroni's test after ANOVA).
In an attempt to examine whether a lack of Cdkl5 triggers apoptotic
cell death we evaluated the number of apoptotic cells in the DG by
counting the number of cells that expressed cleaved caspase-3
(Fig. 2B). Most of the apoptotic cells were in the innermost portion of
the granule cell layer. We observed an increase in cell death in both
Cdkl5−/− and Cdkl5−/Y mice (+40± 3.4% and+32± 2.9%, respec-
tively; p b 0.001 Bonferroni's test after ANOVA; Fig. 2B) compared to
wild type mice and a less pronounced but signiﬁcant increase in
Cdkl5+/−mice (+14 ± 1.9; p b 0.01 Bonferroni's test after ANOVA;
Fig. 2B). This evidence suggests that a lack of Cdkl5 decreases the surviv-
al rate of newborn cells in Cdkl5 KO mice.
Loss of Cdkl5 speciﬁcally decreases survival of postmitotic neurons
We examined the phenotype of the surviving cells 30 days after
BrdU administration through immunoﬂuorescent double-labeling for
BrdU and either a neuronal marker (NeuN) or an astrocytic marker
(GFAP). Both Cdkl5−/− and Cdkl5−/Y mice had fewer (−20 ± 2.0%
and −30 ± 2.5%, respectively; p b 0.001 and p b 0.01, Bonferroni's
test after ANOVA) new neurons (NeuN/BrdU positive cells; Fig. 3A, B)
in comparison with wild type mice, a similar number of new astrocytes
(GFAP/BrdU positive cells; Fig. 3A, B) and a larger number of cells with
an undetermined phenotype (+190 ± 12% and +300 ± 27%, respec-
tively; p b 0.001 and p b 0.01, Bonferroni's test after ANOVA; other;
Fig. 3A, B). A similar effect was also found in Cdkl5+/− mice
(Fig. 3A). These data show that the lack of Cdkl5 dampens the formation
of new granule neurons without affecting astrogliogenesis.
In the course of adult hippocampal neurogenesis, new cells within
the subgranular zone (SGZ) of the DG go through a series of stages asso-
ciatedwith proliferative activity, from the stem cell stage (type 1) to the
intermediate progenitor stages (type 2/3), and onto postmitotic matu-
ration (Kempermannet al., 2004) (Fig. 4A). Doublecortin (DCX) iswide-
ly expressed by the actively dividing type 2b and type 3 intermediate
progenitor cells and by immature granule neurons (Fig. 4A). To deter-
mine whether the loss of Cdkl5 speciﬁcally affects a particular stage of
granule cell formation, we labeled brain sections of wild type and
Cdkl5 KO mice with DCX. As shown in Fig. 4B, DCX positive cells were
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Fig. 1. Neuronal precursor proliferation in the dentate gyrus of Cdkl5 KO mice. A, B: Animals were injected with BrdU for ﬁve consecutive days and sacriﬁced 24 h after the last BrdU
injection on P45. Examples of sections processed for ﬂuorescent immunostaining for BrdU from the dentate gyrus (DG) of wild type (+/+) and homozygous (−/−) Cdkl5 KO female
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57C. Fuchs et al. / Neurobiology of Disease 70 (2014) 53–68present in the SGZ anddeepest portion of the granule cell layer (Fig. 4B).
While the orientation of type 2b/3 cells is parallel to the SGZ (Fig. 4A, B;
asterisks), immature granule neurons have a vertical orientation
and extend long apical processes into the granule cell layer (Fig. 4A, B;
arrows). Based on these features, it was possible to divide DCX positive
cells into two stages of development: type 2b/3 cells and immature neu-
rons.We found that Cdkl5 KOmice hadmore 2b/3 type cells in compar-
ison with wild type mice but a reduced number of immature neurons
(Fig. 4C). These data indicate that the lack of Cdkl5 affects type 2b/3cells (mitotic cells) and differentiating (postmitotic) neurons in an op-
positemanner. This is consistentwith the increased number of undiffer-
entiated cells (other) and the reduced number of cells differentiated
into neurons (NeuN/BrdU positive cells) found in Cdkl5 KO mice (see
Fig. 3A, B). In order to establish whether the reduced number of imma-
ture neurons in KOmice was due to an increase in cell death, we evalu-
ated the number of cells that were positive for both DCX and cleaved
caspase-3.We found that Cdkl5 KOmice showed a notably higher num-
ber of DCX/cleaved caspase-3 positive immature neurons in comparison
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DCX/caspase-3 positive 2b/3 type cells (Fig. 4D, E). To establishwhether
nestin-positive primary progenitor cells (type 1) and intermediateprogenitor cells (type 2a) (Fig. 4A) also exhibit an increase in apoptotic
cell death, we evaluated the number of cells that were positive for both
nestin and cleaved caspase-3. We found that Cdkl5 KOmice showed no
difference in the number of nestin/caspase-3 positive 1/2a type cells in
comparison with wild type mice (Supplementary Fig. 1). This evidence
suggests that the reduced number of new neurons in Cdkl5 KO mice
(see Figs. 3 and 4C) is due to an increase in cell death that speciﬁcally
affects early postmitotic neurons.
Loss of Cdkl5 results in a reduced net number of granule cells in the dentate
gyrus
To establish the impact of the reduction in the number of newly-
formed granule neurons in Cdkl5 KO mice on the overall granule
cell number, we stereologically evaluated the total granule cell number
inmice aged 45 and 75 days.We foundno difference between Cdkl5 KO
andwild typemice in the volume of the granule cell layer (Fig. 5B), but a
reduced granule cell density (Fig. 5C) and a reduced number of granule
cells (Fig. 5D)was present in P45 Cdkl5 KO compared towild typemice.
The reduction in cell numberwas−12±1.2% and−10± 0.5%, respec-
tively, in Cdkl5−/− and Cdkl5−/Y mice, and−8 ± 0.7% in Cdkl5+/−
mice (p b 0.001 and p b 0.01, Bonferroni's test after ANOVA; Fig. 5D).
Similar results were obtained in P75 Cdkl5 KO mice (data not shown).
Consistently with the higher apoptotic cell death in Cdkl5 KOmice esti-
mated by cleaved caspase-3 immunostaining (Fig. 2B), we noted a
higher number of pyknotic nuclei in the innermost granule cell layer
of Cdkl5 KO mice, indicating a larger number of dying cells (Fig. 5A,
arrowheads).
Loss of Cdkl5 results in dendritic hypotrophy of newborn granule cells
Dendritic arborization is signiﬁcantly reduced in the cortical pyrami-
dal neurons of Cdkl5 KOmice compared to their wild type counterparts
(Amendola et al., 2014). The dendritic morphology of newborn granule
cells can be analyzed through immunohistochemistry for DCX, taking
advantage of the expression of this protein in the cytoplasm of imma-
ture neurons during the period of neurite elongation (from 1 to 4
weeks after neuron birth). In order to establish the effect of Cdkl5 loss
on the dendritic development of newborn granule cells, we examined
the dendritic morphology of DCX positive cells. Fig. 4B clearly shows
that DCX positive neurons of Cdkl5 KO mice had fewer processes than
those of their wild type counterparts. Quantiﬁcation of the dendritic
size of DCX positive cells showed that Cdkl5−/− and Cdkl5−/Y mice
had a shorter dendritic length (−44 ± 5% and−34 ± 7%, respectively,
p b 0.01, Bonferroni's test after ANOVA; Fig. 6A) and a reduced number
of segments (−46 ± 2% and −36 ± 9%, respectively, p b 0.05,
Bonferroni's test after ANOVA; Fig. 6B) than wild type mice. The reduc-
tion in dendritic length and number of segments in Cdkl5+/− mice
(−41 ± 6% and −45 ± 4%, respectively; p b 0.01 and p b 0.05
Bonferroni's test after ANOVA; Fig. 6A, B) was very similar to that
found in Cdkl5−/−mice.
To dissect the effects of CDKL5 loss on the details of dendritic archi-
tecture, we examined each dendritic order separately. A striking feature
of Cdkl5 KO mice was the absence of branches of higher order. While
wild type female mice had up to nine orders of branches, Cdkl5−/−
and Cdkl5+/− mice lacked branches of orders 7–9 (Fig. 6C, arrows).
In addition, Cdkl5−/− and Cdkl5+/−mice showed a reduced branch
length of orders 4–7 (Fig. 6C) and a reduced number of branches of or-
ders 5 and 6 (Fig. 6D). Altogether, similar alterations were found when
comparing Cdkl5−/Y and wild type mice (Fig. 6C, D). Taken together,
these data indicate that in Cdkl5 KOmice the dendritic tree of the new-
born granule cells is hypotrophic and that this defect is due to a reduc-
tion in the number and length of branches of intermediate order and a
lack of branches of higher order.
It is likely that a reduction in connectivity is the counterpart of the
dendritic hypotrophy that characterizes the newborn granule cells of
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vesicle glycoprotein that is a speciﬁc marker of presynaptic terminals.
We found that in Cdkl5 KO mice the optical density of SYN was signiﬁ-
cantly lower than in wild type mice in the outer (O), middle (M) and
inner (I) molecular layer (Fig. 6E, F), suggesting that Cdkl5 KO mice
had fewer synaptic contacts in the DG.
Loss of Cdkl5 increases proliferation rate and apoptotic cell death in the SVZ
Weexamined the effect of Cdkl5 loss in the SVZ, a region that, similar
to the SGZ of the DG, retains a neurogenic potential in the adult brain.
Observation of images from the SVZ of Cdkl5 KO and wild type mice
clearly showed that Cdkl5 KO mice had more Ki-67 positive cells
(Supplementary Fig. 2A). Quantiﬁcation of the number of Ki-67 positive
cells showed that both Cdkl5−/− and Cdkl5−/Y mice had more Ki-67
positive cells (+30± 5% and+20± 3.9%, respectively; p b 0.01 and
p b 0.05, Bonferroni's test after ANOVA; Supplementary Fig. 2B) com-
pared to wild type mice. A less pronounced but signiﬁcant disparity in
the number of proliferating cells was found in Cdkl5+/− mice com-
pared to wild type mice (+14 ± 3.7%, p b 0.05 Bonferroni's test after
ANOVA; Supplementary Fig. 2B). Evaluation of the total number of apo-
ptotic cells, showed that in the SVZ of Cdkl5−/−, Cdkl5+/−
and Cdkl5−/Y mice there were more apoptotic cells (+21 ± 2.7%,
+15 ± 2.4%, +21 ± 3.9%, respectively; p b 0.01 and p b 0.05,
Bonferroni's test after ANOVA; Supplementary Fig. 2C, D) than in their
wild type counterparts.
Alterations in the AKT/GSK-3β pathway are involved in neurogenesis and
neuronal maturation defects in Cdkl5 KO mice
Glycogen synthase kinase 3 (GSK-3β) is a ubiquitously active serine/
threonine kinase which is inhibited upon phosphorylation at Ser9 byactivated protein kinase B (PKB/AKT). GSK-3β (dephosphorylated at
Ser9) is a crucial inhibitory regulator of many neuronal functions, in-
cluding neurite outgrowth, synapse formation, neurogenesis and sur-
vival of newly-generated neurons (Cole, 2012). The AKT/GSK-3β
pathway exerts its functions by modulating the activity of a wide
range of substrates (Cole, 2012). An outline of key elements of this path-
way is reported in Fig. 7A.We and others had previously shown the dis-
ruption of AKT/mTOR/S6 signaling in Cdkl5 KO mice (Amendola et al.,
2014; Wang et al., 2012) (diagram in Fig. 7A). In the current study we
were interested in establishing whether the AKT/GSK-3β pathway is
also deregulated in Cdkl5 KO mice. Evaluation of the phosphorylation
levels of the AKT/GSK-3β pathway showed lower phosphorylation
levels of: i) PDK1 (PDK1 stands at the head of the AKT/GSK-3β pathway
by phosphorylating AKT), ii) AKT, at its two critical residues namely
Thr308 and Ser473, iii) GSK-3β at Ser9 (its inhibitory site), and
iv) CREB at Ser133 in Cdkl5 KO in comparison with wild type mice
(Fig. 7B, C). While CREB phosphorylation and consequent DNA binding
is inhibited by activated (Ser9 dephosphorylated) GSK-3β (diagram in
Supplementary Fig. 3) (Grimes and Jope, 2001), collapsin response
mediator protein-2 (CRMP-2) is phosphorylated and consequently
inactivated by GSK-3β (Supplementary Fig. 3) (Yoshimura et al.,
2005). In contrast, GSK-3β controls the amount of β-catenin by nega-
tively regulating β-catenin protein stability (Supplementary Fig. 3)
(Wada, 2009). In line with an increased activity of GSK-3β, we found
higher phosphorylation levels of CRMP2 and lower levels of β-catenin
(Fig. 7B, C). No differences were found between Cdkl5 KO and wild
type mice in the phosphorylation levels of ERK (Fig. 7B, C), suggesting
a speciﬁc alteration of the AKT/GSK-3β pathway in the absence of Cdkl5.
This evidence suggests that alteration of the AKT/GSK-3β path-
way may underlie the developmental defects due to loss of CDKL5.
In order to clarify this issue, we used cultures of neuronal precursor
cells (NPCs) from Cdkl5 KO mice. We ﬁrst sought to establish
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60 C. Fuchs et al. / Neurobiology of Disease 70 (2014) 53–68whether cultures of NPCs exhibit the same defects observed in vivo.
Neurospheres derived from the SVZ of homozygous (−/−) Cdkl5 KO
females exhibited a higher proliferation rate compared to those of
their wild type counterparts (+15 ± 1.9%, p b 0.01 Bonferroni's testafter ANOVA; Fig. 8A). No difference in apoptotic cell death was ob-
served between wild type and Cdkl5 KO neurospheres, as estimated
through cleaved caspase-3 immunostaining (Fig. 8B) and the pyknotic
appearance of the nuclei of dying cells (data not shown). This conﬁrms
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61C. Fuchs et al. / Neurobiology of Disease 70 (2014) 53–68that loss of Cdkl5 does not induce an increase in cell death during the
stage of proliferation of NPCs. In order to determine the effect of Cdkl5
loss on cell death in post-mitotic NPCs, we evaluated the number of
cleaved caspase-3 positive cells after 1 day in differentiating culture
conditions. We found that cultures of differentiating NPCs from (−/−)
female Cdkl5 KO mice exhibited a notably higher number of caspase-3
positive cells in comparison with their wild type counterparts
(+350 ± 17%, p b 0.001, Bonferroni's test after ANOVA; Fig. 8C),
conﬁrming that a loss of Cdkl5 is accompanied by an increase in celldeath during the stage of differentiation. A signiﬁcant difference
in cell survival rate was also found in NPCs from heterozygous (+/−)
female Cdkl5 KO mice (187 ± 21.4 %; p b 0.01 Bonferroni's test after
ANOVA; data not shown), which may be consistent with a mosaic of
knockout and wild type cells. Evaluation of the number of new neurons
(β-tubulin III positive cells) and new astrocytes (GFAP positive cells)
after 7 days of differentiation showed that in differentiated cultures of
Cdkl5−/− NPCs the number of neurons was remarkably smaller com-
pared to wild type NPCs (−82 ± 7%, p b 0.001, Bonferroni's test after
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62 C. Fuchs et al. / Neurobiology of Disease 70 (2014) 53–68ANOVA; Fig. 8D), while there was no difference in the number of astro-
cytes (Fig. 8D). A reduction in the number of new neurons was also
found in Cdkl5+/− mice (−67 ± 11.1 %; p b 0.01 Bonferroni's
test after ANOVA; data not shown). This conﬁrms that an absence of
CDKL5 speciﬁcally decreases the survival of postmitotic neurons. As-
sessment of neurite outgrowth in β-tubulin III positive cells revealed
that neurons generated from Cdkl5−/− NPCs were less differentiated
in comparison with wild type neurons (−40 ± 6.9%, p b 0.01,
Bonferroni's test after ANOVA; Fig. 8D). A reduction in neurite length
was also found in Cdkl5+/− NPCs (−35 ± 8.1 %; p b 0.05 Bonferroni's
test after ANOVA; data not shown). These results conﬁrm that post-mitotic NPCs from Cdkl5 KO mice have an intrinsic defect, not only in
cell survival, but also in neuronal maturation. Evaluation of the AKT/
GSK-3β pathway activation in cultures of Cdkl5 KO NPCs showed
lower levels of phosphorylated AKT and GSK-3β (Fig. 8E).
In order to obtain evidence that the neurodevelopmental defects
observed in Cdkl5 KO mice and Cdkl5 KO NPCs were due to a loss of
Cdkl5, we re-expressed Cdkl5 in cultures of NPCs. We found that an
adenovirus-mediated expression of Cdkl5 in NPCs from Cdkl5 KO mice
(Fig. 8B) restored cell proliferation (Fig. 8B), neuronal survival and
maturation (Fig. 8C, D). Importantly, we also found a parallel restoration
of the phosphorylation levels of AKT and GSK-3β (Fig. 8E), conﬁrming
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Next, we treated Cdkl5 KO NPCs with an inhibitor of GSK3β activity.
We used lithium, a well-known inhibitor of GSK3β activity that acts
both indirectly, by increasing the inhibitory phosphorylation of GSK-
3β, and directly, by antagonizing its kinase activity (Jope, 2003). We
found that, in NPCs from Cdkl5 KO mice, the lithium-induced increase
in the GSK-3β phosphorylation (Fig. 8E) was accompanied by a com-
plete restoration of neuronal survival, number of new neurons and
neuronal maturation (Fig. 8C, D). These data suggest that the alteration
of AKT/GSK-3β signaling due to a loss of CDKL5 expression plays a role
in the developmental alterations observed in Cdkl5 KO mice.Loss of Cdkl5 impairs hippocampus-dependent behavior
In order to examine the functional correlate of the developmental
abnormalities observed in the hippocampus of Cdkl5 KO mice, we
evaluated spatial working memory by using the Y-maze paradigm.
This test assesses the working memory, preferentially exploring
the prefrontal cortex–hippocampus network (Paul et al., 2009), and
is widely used to examine the impact of adult neurogenesis on
hippocampus-dependent memory tasks (Hou et al., 2013). The per-
centage of spontaneous alternation was calculated as an index of
spatial working memory. We found that while wild type mice
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64 C. Fuchs et al. / Neurobiology of Disease 70 (2014) 53–68entered more frequently into the novel, previously unvisited arm of
the maze (Fig. 9A), Cdkl5 KO mice showed no preference toward
the novel arm and entered randomly into the different arms approx-
imately with the same frequency (Fig. 9A). It is to be noted that thisdifference was not due to a reduced motility, because Cdkl5 KO mice
traveled the same distance as wild type mice (Fig. 9B). These results
suggest that mice lacking Cdkl5 have deﬁcits in spatial working
memory.
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*p b 0.05; **p b 0.01; ***p b 0.001 (Dunnett's test after ANOVA).
Table 1
Summary of the effects of Cdkl5 loss on Cdkl5 KO mice.
P45 mice
Genotype +/+ +/− +/Y −/Y
Measure Region N =
Proliferation DG = ≥ N = N
SVZ = N N = N
Cell death DG = N N = N
SVZ = N = = N
Cell death
(type 1/2a cells)
DG = = = = =
Cell death
(type 2b/3 cells)
DG = = N = =
Cell death
(immature neurons)
DG = N = = N
Volume DG = = b = =
Cellularity DG = b b = b
Dendrites
(length and number)
DG = b b = b
SYN levels Mol = b b = b
pPDK1 levels HF = b b = b
pAKT levels HF = b b = b
pGSK3-β levels HF = b = = b
pERK levels HF = = b = =
pCREB levels HF = b N = b
pCRMP2 levels HF = N b = N
β -catenin levels HF = b b
P75 mice
Genotype +/+ +/− −/− +/Y −/Y
Measure Region
No. of surviving cells DG = b b = b
No. of new neurons DG = b b = b
No. of new astrocytes DG = = = = =
Volume DG = = = = =
Cellularity DG = b b = b
Dendrites
(length and number)
DG = b b = b
Effect of genotype on different aspects of brain development (Measure column) in mice
aged 45 days (P45) and 75 days (P75). These mice were the progeny of Cdkl5 KO +/−
females crossed with Cdkl5 KO Y/− males or Cdkl5 KO +/− females with Y/+ males.
The regionswhere thedifferentmeasurementswere carried out are indicated (Region col-
umn). The effect of genotype refers to the corresponding gender wild type Cdkl5 KOmice
(+/+; +/Y). The symbols b and N indicate a lower and higher value, respectively, in
comparisonwithwild type Cdkl5 KOmice. The symbol ≥ indicates a higher but not signif-
icant value while the symbol = indicates a value similar to that of wild type Cdkl5 KO
mice. Abbreviations: DG, dentate gyrus; HF, hippocampal formation; Mol, molecular
layer of the DG; SVZ, subventricular zone.
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The role of CDKL5 regarding brain development is still largely un-
known. In this study,we provide novel evidence that CDKL5 plays a fun-
damental role in postnatal neurogenesis, by affecting neural precursor
proliferation aswell as the survival andmaturation of newborn neurons
(Table 1).
CDKL5 promotes the survival and maturation of postmitotic neurons
In the hippocampal SGZ, primary progenitor cells (type-1) produce
intermediate progenitor cells (IPCs), which are a type of transit amplify-
ing cell. Undifferentiated IPCs (type-2a and type-2b) divide rapidly to
produce neuronal committed IPCs (type-3). Type-3 IPCs generate im-
mature neurons that integrate into the hippocampal circuits as mature
granule cells within 1 month (Fig. 10). The majority of these immature
neurons are subjected to a selection process, during which they are ei-
ther recruited into function or eliminated (Biebl et al., 2000). We
found here that Cdkl5 loss caused an increase in apoptotic cell death
of immature neurons with no effect on IPCs (see Fig. 4B), suggesting
that CDKL5 plays a pro-survival role toward postmitotic granule neu-
rons. We additionally found that differentiating (postmitotic) NPCs
from the SVZ of Cdkl5 KOmice underwent an increase in cell death, sug-
gesting a generalized role of CDKL5 in the survival of immature neurons
in different brain regions. Previous observations showed that CDKL5un-
dergoes an expression increase in differentiating neurons (Valli et al.,
2012), consistently with its pro-survival role in postmitotic neurons
suggested by the current study. We found that while the loss of
CDKL5 speciﬁcally causes the death of immature neurons, it increases
proliferation rate of IPCs (see Figs. 1 and 4). The latter ﬁnding is in agree-
ment with previous evidence showing an anti-proliferative role of this
gene in neural precursor cells (Valli et al., 2012). Evaluation of
the total number of granule cells in the DG showed that Cdkl5 KO
mice were characterized by hypocellularity, indicating that the process
of apoptotic cell death of immature granule neurons overrides the
proliferation increase of their progenitors. Regarding the process of
astrogliogenesis we found that a loss of Cdkl5 did not change the num-
ber of cells that acquired an astrocytic phenotype. This is in agreementwith the lowexpression of CDKL5 in astrocytes in comparisonwith neu-
rons (Rusconi et al., 2008). Taken together, these data suggest that
CDKL5 plays an important role in the process of neurogenesis, but not
in astrogliogenesis.
Dendritic arborization is signiﬁcantly reduced in cortical pyramidal
neurons from both RTT subjects (Armstrong et al., 1999; Belichenko
et al., 2008, 2009) and Mecp2 knockout mice (Kishi and Macklis,
2005; Stuss et al., 2012). It is not known whether similar deﬁcits exist
in the brains of subjects carrying CDKL5 mutations. We previously
showed that dendritic arborization is signiﬁcantly reduced in cortical
pyramidal neurons and hippocampal neurons in the Cdkl5 KO mouse
model (Amendola et al., 2014), suggesting that this gene has a role in
dendritic development and/or stabilization. Taking advantage of the
mainly postnatal generation of hippocampal granule cells, we examined
here the dendritic pattern of newly-generated granule neurons (see
Fig. 6).We found that a loss of Cdkl5 causes dendritic hypotrophy,main-
ly due to a lack of dendritic branches of higher order. This suggests that
CDKL5 plays an important role in the regulation of dendritic develop-
ment. The ﬁnding that Cdkl5 KOmice had reduced SYN levels in themo-
lecular layer of the DG suggests a reduction in the number of synaptic
terminals, which is consistent with the reduced dendritic surface of
granule cells.
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Fig. 10. Hypothetical model of CDKL5 function in postnatal hippocampus development.
Top: In the normal dentate gyrus, primary progenitor cells (type 1) and intermediate pro-
genitor cells (type 2a/b and type 3 cells) continue to proliferate, maintaining the normal
progenitor pool. Postmitotic immature neurons differentiate into mature granule cells.
Some of the immature neurons are committed to die. Bottom: A loss of Cdkl5 increases
the proliferation rate of type 1, type 2a/b and type 3 cells but causes an increase in cell
death of immature neurons, with a reduction in the ﬁnal number of mature granule
cells. Moreover immature neurons exhibit a hypotrophic dendritic tree.
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Results from several laboratories suggest that adult hippocampal
neurogenesis is functional and is involved in learning and memory per-
formance (Castilla-Ortega et al., 2011; Vadodaria and Jessberger, 2014).
It is well established that inhibition of hippocampal neurogenesis im-
pairs learning and memory (Pan et al., 2012; Shors et al., 2001), while
stimulation of neurogenesis enhances cognitive performance, and
increased neurogenesis improves the LTP of synaptic transmission
(Jun et al., 2012; van Praag et al., 1999). Dendritic pathology is a possible
substrate for mental retardation in different conditions. In RTT, the
pathogenesis of dendritic abnormalities is distinctive and appears to
correlate with the cognitive proﬁle. We have shown that Cdkl5 KO
mice not only exhibit an impaired neurogenic capacity but also a severe
dendritic hypotrophy. Consistently with these neuroanatomical defects,
Cdkl5 KO mice exhibited impairment in hippocampus-dependent
memory. Given that cortical areas share the same defects observed
here in the hippocampus of Cdkl5 KOmice, this may explain the severe
cognitive impairment of individuals with CDKL5 mutations.
AKT/GSK-3β signaling plays a central role in the CDKL5-dependent regula-
tion of neurogenesis and dendritic development
AKT/GSK-3β signaling regulates diverse developmental events in
the brain, including neurogenesis, neuron survival and differentiation
(Luo, 2012). For example, activation of GSK-3β promotes apoptotic sig-
naling in cultured neural precursor cells (Eom et al., 2007), and neuro-
nal overexpression of GSK-3β causes delayed postnatal maturation
and differentiation of neurons in the mouse brain (Spittaels et al.,
2000, 2002). We found that the neurogenesis and neuron maturation
defects due to Cdkl5 loss were associated with impairment of the AKT/
GSK-3β signaling pathway. Re-expression of CDKL5 restoredNPC prolif-
eration, survival and differentiation with a parallel restoration of the
AKT/GSK-3β signaling. These results strongly suggest that a loss of
Cdkl5 impairs neuron survival and maturation by disrupting the AKT/
GSK-3β signaling pathway. This conclusion is strengthened by the ob-
servation that reinstatement of GSK-3β phosphorylation (inactivation)
in Cdkl5 KO NPCs through the administration of lithium results in the
full recovery of neuronal precursor survival and maturation. In view ofthe indirect action of lithium on other cellular signaling pathways
(Kang et al., 2003; Pardo et al., 2003; Sasaki et al., 2006), a contribution
of additional pathways cannot be ruled out. Signaling alterations of AKT/
mTOR/rpS6 have recently been identiﬁed in Cdkl5 KO mouse models
(Amendola et al., 2014; Wang et al., 2012), suggesting that CDKL5
may coordinate multiple signaling cascades downstream to AKT. It re-
mains to be established whether these signaling cascades are directly
or indirectly engaged by CDKL5. Together, these data suggest a central
role of the AKT/GSK-3β signaling pathway in the CDKL5-dependent reg-
ulation of neurogenesis and neuron maturation and point toward the
AKT/GSK-3β pathways as a potential therapeutic target for the treat-
ment of CDKL5-related disorders.Mosaic loss of Cdkl5 is sufﬁcient to impair brain phenotype
Mammalian female cells randomly inactivate one of the two X chro-
mosomes in somatic cells, and the genes on the inactive X chromosome
(with a few exceptions) are not expressed. X-chromosome inactivation
(XCI) occurs before the completion of gastrulation during early embry-
onic development and is believed to be irreversible (Plath et al., 2002).
Most CDKL5 patients are females who are heterozygous for CDKL5 deﬁ-
ciency due to random XCI. In the current study we examined not only
the phenotype of heterozygous Cdkl5 KO female mice, that mimics
that of CDKL5 female patients, but also the phenotype of homozygous
female and hemizygous male Cdkl5 KO mice. We found that a loss of
Cdkl5 in heterozygous femalemice caused decreased survival and aber-
rant dendritic development of newly generated granule cells and be-
havioral impairment. This indicates that a mosaic loss of CDKL5 in 50%
of cells in the brain alters neuronal survival/differentiation in a manner
that is sufﬁcient to impair cognitive performance. As expected, homozy-
gous female and hemizygousmalemice had amore severe brain pheno-
type due to Cdkl5 loss in 100% of cells.Conclusion
Taken together, our data suggest that CDKL5modulates the intricate
balance between precursor proliferation/survival and differentiation
during the process of postnatal neurogenesis (Fig. 10). It isworth noting
that the phenotype of Cdkl5 knockout mice only partially overlaps with
that of Mecp2 knockouts. While both mutants show severe dendritic
hypotrophy (Amendola et al., 2014; Smrt et al., 2007), there is no evi-
dence for altered neural precursor proliferation and survival in Mecp2
KO mice. Translation of this evidence to the human condition suggests
that dendritic hypotrophy may explain common phenotypic features
in individuals with CDKL5 disorder and RTT. On the other hand, reduc-
tion in neuron survival appears to be a typical feature of CDKL5 disorder
that may explain phenotypes that are not shared with RTT.
We suggest that a loss of Cdkl5 impairs neurogenesis and dendritic
development by disrupting the AKT/GSK-3β signaling pathway. Disrup-
tion of neurogenesis and dendritic development in the hippocampus
leads to alterations in cognitive performance. The transfer of these
data to the human pathology suggests that a generalized impairment
of key processes of brain development may underlie the generalized
and severe cognitive impairment in individuals with CDKL5 disorder.
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